Skip to main content

Table 5 Disease-free survival of the studied AML patients

From: Interleukin-4 gene intron 3 VNTR polymorphism in adult acute myeloid leukemia

Groups Total N N of events PFS (months) 95% CI PFS at (%) months Log Rank Test
Median SE Lower Upper 3 months (%) 6 months (%) 12 months (%) X2 P value
P1P1 and P1P2 18 2 19.500 2.756 14.099 24.901 75.00 75.00 75.00 0.345 0.557
P2P2 22 6 17.513 2.123 13.351 21.674 90.00 78.80 59.10   
  1. DFS disease-free survival, SE standard error, N number